The role of platelet-rich plasma and stem cells in the management of osteoarthritis: Current evidence, clinical positioning, and translational challenges.
Current evidence does not support routine, indiscriminate, or first-line use of regenerative injections in knee OA, so PRP and MSC-based and other cell-based therapies remain less established and require further rigorous evaluation before broader clinical adoption.